Stockscreener 앱 받기
7.31
1.72%
0.06
전일 마감가:
$7.25
열려 있는:
$7.26
하루 거래량:
142.95K
Relative Volume:
0.63
시가총액:
$243.46M
수익:
$50.14M
순이익/손실:
$-35.38M
주가수익비율:
-5.2214
EPS:
-1.4
순현금흐름:
$-39.46M
1주 성능:
-19.92%
1개월 성능:
-14.44%
6개월 성능:
-42.70%
1년 성능:
-11.68%
1일 변동 폭
$7.0434
$7.42
1주일 범위
$6.60
$9.845
52주 변동 폭
$6.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
명칭
Avita Medical Inc
전화
661-568-1317
주소
28159 AVENUE STANFORD, VALENCIA, CA
RCEL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
7.325 | 243.46M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
129.51 | 230.70B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.77 | 154.22B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.71 | 145.74B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.21 | 107.03B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.88 | 44.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-24 | 개시 | D. Boral Capital | Buy |
| 2024-04-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 개시 | Piper Sandler | Overweight |
| 2020-08-27 | 개시 | BofA Securities | Buy |
| 2020-04-21 | 개시 | Oppenheimer | Outperform |
| 2020-03-03 | 개시 | BTIG Research | Buy |
모두보기
Avita Medical Inc 주식(RCEL)의 최신 뉴스
AVITA Medical's Acute Wound Care Showcase 2025 Streams Live Today - The Manila Times
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today - Stock Titan
AVITA Medical: Near Perfect Execution Needed To Navigate Through Balance Sheet Challenges - Seeking Alpha
Why AVITA, Botanix, Brainchip, and NAB shares are falling today - The Motley Fool Australia
Analysts Have Been Trimming Their AVITA Medical, Inc. (NASDAQ:RCEL) Price Target After Its Latest Report - Yahoo Finance
Contrasting GBS (NYSE:GBS) and AVITA Medical (NASDAQ:RCEL) - Defense World
Wells Fargo & Company MN Boosts Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2025 Earnings Call Transcript - Insider Monkey
Cantor maintains Avita Medical stock Overweight, $19 target post-Q1 By Investing.com - Investing.com Canada
AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance - MSN
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL St - GuruFocus
Avita Medical Shares Decline on 1Q Revenue Miss - MarketWatch
Barclays PLC Purchases 3,526 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical (RCEL) Target Price Adjusted by TD Cowen | RCEL Stock News - GuruFocus
Avita’s Road to Profitability Is in Sight - Morningstar
AVITA Medical (RCEL) Sees Revenue Surge with Product Launches - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Stro - GuruFocus
Avita Medical Earnings: Fair Value Estimate Cut on Unlikely Vitiligo Reimbursement Support - Morningstar
AVITA Medical Inc (AVHHL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Shifts - GuruFocus
AVITA Medical Reports Strong Q1 2025 Growth - TipRanks
Avita Medical's Loss Narrows in Q1 as Revenue Grows; Shares Down 20% - marketscreener.com
AVITA Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
AVITA Medical Q1 2025 slides reveal growth strategy as stock tumbles on earnings miss - Investing.com Canada
AVITA Medical (RCEL) Reports Significant Revenue Growth with New Product Launches | RCEL Stock News - GuruFocus
AVITA Medical Reports First Quarter 2025 Financial Results - The Manila Times
AVITA Medical (RCEL) Projected to Post Earnings on Thursday - MarketBeat
(RCEL) Long Term Investment Analysis - news.stocktradersdaily.com
AVITA Medical, Inc. (NASDAQ:RCEL) Shares Bought by JPMorgan Chase & Co. - Defense World
Russell Investments Group Ltd. Acquires 2,324 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Geode Capital Management LLC Raises Stock Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025 - Stock Titan
Avita Uses Its Tech To Treat Wounds - Los Angeles Business Journal
AVITA Medical to Announce First Quarter 2025 Financial Results - The Manila Times
AVITA Medical to Announce First Quarter 2025 Financial Results | RCEL Stock News - GuruFocus
Leading Wound Care Company AVITA Medical Announces Q1 2025 Earnings Call Details - Stock Titan
The new medical device company to watch - Morningstar
Vanguard Group Inc. Has $18.22 Million Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc. Announces Chief Executive Officer Changes - marketscreener.com
D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World
AVITA Medical, Inc.'s (NASDAQ:RCEL) Profit Outlook - simplywall.st
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 | RCEL Stock News - GuruFocus
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025 - The Manila Times
AVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Earns “Buy” Rating from D. Boral Capital - Defense World
6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga
AVITA Medical Announces US Commercial Launch Of Cohealyx - marketscreener.com
Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener
AVITA Medical launches Cohealyx in the U.S. market By Investing.com - Investing.com South Africa
AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times
Avita Medical Inc (RCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Avita Medical Inc 주식 (RCEL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
| O'Toole David D | CFO |
May 30 '24 |
Buy |
8.90 |
1,000 |
8,900 |
19,734 |
0.27%
0.39%
자본화:
|
볼륨(24시간):